Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906.

Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leuk Lymphoma. 2006 Aug; 47(8):1511-7.

View in: PubMed

subject areas

Adult
Aged
Burkitt Lymphoma
Disease-Free Survival
Doxorubicin
Enzyme Inhibitors
Female
Humans
Lymphoma, Non-Hodgkin
Male
Middle Aged
Recurrence
Remission Induction
Salvage Therapy
Topoisomerase I Inhibitors
Topotecan

authors with profiles

Sonali Smith